These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 24372145)
61. Potential of X-ray free-electron lasers for challenging targets in structure-based drug discovery. Nass Kovacs G Drug Discov Today Technol; 2021 Dec; 39():101-110. PubMed ID: 34906320 [TBL] [Abstract][Full Text] [Related]
62. MicroED for the study of protein-ligand interactions and the potential for drug discovery. Clark LJ; Bu G; Nannenga BL; Gonen T Nat Rev Chem; 2021 Dec; 5(12):853-858. PubMed ID: 37117388 [TBL] [Abstract][Full Text] [Related]
63. [Progress in the fragment-based drug discovery]. Ren J; Li J; Shi F; Wang X; He JH; Xu YC; Zhang NX; Xiong B; Shen JK Yao Xue Xue Bao; 2013 Jan; 48(1):14-24. PubMed ID: 23600136 [TBL] [Abstract][Full Text] [Related]
66. Determination of the three-dimensional structure of toxins by protein crystallography. Souza DH; Selistre-de-Araujo HS; Garratt RC Toxicon; 2000 Oct; 38(10):1307-53. PubMed ID: 10758270 [TBL] [Abstract][Full Text] [Related]
67. Simulating diffraction photographs based on molecular dynamics trajectories of a protein crystal: a new option to examine structure-solving strategies in protein crystallography. Liu N; Mikhailovskii O; Skrynnikov NR; Xue Y IUCrJ; 2023 Jan; 10(Pt 1):16-26. PubMed ID: 36598499 [TBL] [Abstract][Full Text] [Related]
68. The utility of structural biology in drug discovery. Tari LW Methods Mol Biol; 2012; 841():1-27. PubMed ID: 22222446 [TBL] [Abstract][Full Text] [Related]
69. Experiences From Developing Software for Large X-Ray Crystallography-Driven Protein-Ligand Studies. Pearce NM; Skyner R; Krojer T Front Mol Biosci; 2022; 9():861491. PubMed ID: 35480897 [TBL] [Abstract][Full Text] [Related]
70. An Overview of Microcrystal Electron Diffraction (MicroED). Mu X; Gillman C; Nguyen C; Gonen T Annu Rev Biochem; 2021 Jun; 90():431-450. PubMed ID: 34153215 [TBL] [Abstract][Full Text] [Related]
72. Microcrystal electron diffraction in macromolecular and pharmaceutical structure determination. Clabbers MTB; Xu H Drug Discov Today Technol; 2020 Dec; 37():93-105. PubMed ID: 34895659 [TBL] [Abstract][Full Text] [Related]
73. Validation of ligands in macromolecular structures determined by X-ray crystallography. Smart OS; Horský V; Gore S; Svobodová Vařeková R; Bendová V; Kleywegt GJ; Velankar S Acta Crystallogr D Struct Biol; 2018 Mar; 74(Pt 3):228-236. PubMed ID: 29533230 [TBL] [Abstract][Full Text] [Related]
74. Macromolecular X-ray crystallography: soon to be a road less travelled? Beale JH Acta Crystallogr D Struct Biol; 2020 May; 76(Pt 5):400-405. PubMed ID: 32355036 [TBL] [Abstract][Full Text] [Related]
75. Words of advice: teaching macromolecular crystallography. Srinivasan B FEBS J; 2023 Dec; 290(23):5441-5455. PubMed ID: 37014311 [TBL] [Abstract][Full Text] [Related]
76. The role of experimental and computational structural approaches in 7TM drug discovery. Topiol S; Sabio M Expert Opin Drug Discov; 2015 Oct; 10(10):1071-84. PubMed ID: 26211671 [TBL] [Abstract][Full Text] [Related]
77. Long-Wavelength X-Ray Diffraction and Its Applications in Macromolecular Crystallography. Weiss MS Methods Mol Biol; 2017; 1607():401-420. PubMed ID: 28573583 [TBL] [Abstract][Full Text] [Related]
78. The young person's guide to the PDB. Minor W; Dauter Z; Jaskolski M Postepy Biochem; 2016; 62(3):242-249. PubMed ID: 28132477 [TBL] [Abstract][Full Text] [Related]